Repatha 140 mg / ml

Repatha 140 mg / ml is a medicine authorised by Swissmedic under authorisation number 65622. The authorisation holder is Amgen Switzerland AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 February 2016 and the authorisation is valid without a time limit. ATC code C10AX13 places the medicine in the group Lipid modifying agents.

  • Dispensing category B
  • Authorisation number 65622
  • ATC C10AX13
  • Biotechnological medicines
Authorisation data
Authorisation number65622
NameRepatha 140 mg / ml
Full nameRepatha 140 mg / ml, Vorgefüllter Pen
Authorisation holderAmgen Switzerland AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeC10AX13
First authorisation05 February 2016
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Repatha 140 mg / ml, Vorgefüllter PenB05 February 2016

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Injektor(en), vorgefüllt/PenC10AX1307.12.0.B
22Injektor(en), vorgefüllt/PenC10AX1307.12.0.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Repatha 140 mg / ml authorised in Switzerland?

Yes. Repatha 140 mg / ml is authorised by Swissmedic under authorisation number 65622, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Repatha 140 mg / ml have?

Repatha 140 mg / ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Repatha 140 mg / ml?

The authorisation holder is Amgen Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com